A Comparison of a specific blood marker for coagulation in Covid 19 patients with and without diabetes as a comorbidities so that to assess the impact of diabetes with covid disease severity

A comparison of D Dimer values in Covid 19 patients with and without Type 2 Diabetes Mellitus

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2021/10/037259

Enrollment

432

Registered

2021-10-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Control Intervention1: Dr Shashikiran U: HOD Medicine department Dr TMA Pai hospital Udupi Control Intervention2: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: ALL COVID POSITIVE PATIENTS FROM ABOVE 18 YEARS OF AGE ADMITTED IN DR TMA PAI HOSPITAL FROM 1 MARCH 2020 TO 30 SEPTEMBER 2020

Exclusion criteria

Exclusion criteria: PATIENTS WITH TYPE 1 DM PATIENTS WITH PRE EXISTING HISTORY OF THROMBOEMBOLISM AND DIC PATIENTS ON ANTICOAGULANTS PREGNANT AND LACTATING WOMEN KNOWN CASE OF CKD AND CLD PATIENTS WITH MALIGNANCY NOT UNDER REMISSION

Design outcomes

Primary

Measure	Time frame
COMPARISON OF D DIMER VALUES IN COVID PATIENTS WITH AND WITHOUT DIABETESTimepoint: 2 YEARS	—

Secondary

Measure	Time frame
COMPARISON OF D DIMER VALUES IN COVID PATIENTS WITH UNCONTROLLED AND CONTROLLED DIABETESTimepoint: 2 YEARS	—

Countries

India

Contacts

Public ContactDR Numan A M

DR TMA PAI Hospital

shashikiran.u@manipal.edu9008418171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026